MCAZ

Circulars

Circular 22 of 2023: Publication of Canceled Wholesale Dealer’s Permits, Pharmacy Licences and Person’s Licences
Size: 1619KB
Circular 17 of 2022: CBD Products
Size: 558kb
Circular 18 of 2023: Fees for Laboratory Analysis Of Complementary Medicines
Size: 497KB
Circular 20 of 2023: Fees schedule
Size: 4200KB
Circular 19 of 2023: Implementation Plan for Re-Registration of Human Allopathic Medicines _Proposed Fees
Size: 708KB
Circular 12 of 2023 : Regulatory Alert Regarding the Selling of Specially Restricted Preparations and Thalidomide
Size: 2083KB
Circular 13 of 2023 Suspension of the Small Business Support Function Till Further Notice
Size: 1188KB
Circular 25 of 2022- Notification of issuance of revised registration certificates for variations at re-registration
Size: 595KB
Circular 11 Of 2023 – Follow-Up Plan for Registration of Human Allopathic Medicines
Size: 1024KB
Circular 14 of 2022 – Implementation Plan for Re-Registration of Human Allopathic Medicines
Size: 1005KB
Circular 6 of 2023 – Instruction to quarantine all Pholcodine-containing products
Size: 1703KB
Published: April 14, 2023
CIRCULAR 5 OF 2023 -INSTRUCTION TO QUARANTINE TETRACYCLINE HYDROCHLORIDE OPHTHALMIC OINTMENT USP 1% MANUFACTURED BY GALENTIC PHARMA (INDIA) PVT, LTD, R-673, T.T.C. MIDC RABALE, THANE-BELAPUR ROAD, NAVI MUMBAI-400701, MAHARASHTRA, INDIA
Size: 587kb
Circular 4 of 2023 – Change of Value Added Tax (TAX) Rate from 14.5% to 15%
Size: 189KB
Circular 02 of 2023- Renewal of Premises and Persons Licences
Size: 511
Circular 01 of 2023- Renewal of Permits and Persons licences for Wholesale dealers, Sales Representative and Pharmacy Technicians
Size: 539KB
Circular 24 of 2022- Importation of Medicines
Size: 894KB
Circular 23 of 2022- Importation of Medicines
Size: 1024BK
Circular 20 of 2022 CBD products clarification
Size: 604KB
Circular 21 of 2022 – Invitation to stakeholders meetings
Size: 254KB
Circular 19 of 2022 – Fees Schedule
Size: 645KB
Published: September 19, 2022
Circular-15-of-2022-Safety-measures-for-sodium-valproate-and-the-risk-of-congenital-malformations-in-neonates-and-neurodevelopmental-disorders-in-children-exposed-to-sodium-valproate-during-pregnancy
Size: 156MB
Published: July 25, 2022
Circular 13 of 2022 Pharmacovigilance system requirements for Pharmaceutical Industry
Size: 289KB
Circular 11 of 2022 Revised MCAZ Clinical Trial Guidelines
Size: 996KB
Published: May 20, 2022
Circular 9 of 2022 Inspection of Premises prior to renewal of Licences and Permits
Size: 38KB
Published: March 31, 2022
Circular 8 of 2022 -Publication of Cancelled Wholesale Dealers’ Permit and Persons’ Licences
Size: 880KB
Published: March 18, 2022
circular 06 of 2022- Renewal of Wholesale Dealers
Circular 02 of 2022- Renewal of Pharmacies
Size: 490kb
Circular 3 of 2022 – Clarification of Conditions for Medicines Registration Requirements and Subsequent Expansion of Registration Certificate, Section 15 Format Annexure
Size: 118KB
Annex1-Template-for-comments-on-Draft-Guideline-for-market-Authorization-Renewal
Size: 25 KB
Circular 5 of 2022 – Publication of Cancelled Premises and Persons’ Licences.
Size: 859KB
Circular 16 of 2021 – Use of Ivermectin human oral formulations for prevention and or treatment of COVID 19
Size: 62KB
Circular 1 of 2022 – Publication of product Information for Registered medicinal Products (Summary of Product Characteristics
Size: 271KB
Circular 4 of 2020 – Preventive Measures to Reduce the Spread of COVID-19 (Coronavirus) by the Medicines Control Authority of Zimbabwe (MCAZ)
Published: April 5, 2021
Circular 3 of 2020-Renewal of Premises Licences- Pharmacies
Published: April 5, 2021
Circular 6 of 2020 – Grace period for renewal of wholesale dealer’s permit 
Size: 551 KB
Published: July 9, 2020

 6,544 total views